Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Coalition of Women Living with HIV and Aids (Cowlha) says an initiative they introduced to promote adherence to ...

As long as key populations are not fully included in HIV prevention, treatment, ... As the world reflects 43 years of HIV and AIDS, it is crucial for Malawi to re-evaluate its commitments to key ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that millions of Africans have taken to prevent infection - particularly ...

Six months after President Donald Trump's foreign aid cuts, millions have lost access to HIV prevention medication.

In early 2025, the US decision to halt foreign aid for HIV/AIDS programs triggered global concerns about a potential ...

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

The World Health Organization (WHO) chief on Monday called on world leaders to prioritize HIV prevention and embrace ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One area that has been particularly hard hit has been research, prevention, and ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...